Avenue Therapeutics shares owned by Citadel Advisors
Quarter-by-quarter ownership of Avenue Therapeutics (ATXI) shares owned by Citadel Advisors
from 13F filings
Historical chart of Citadel Advisors investment in Avenue Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Avenue Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Avenue Therapeutics by Citadel Advisors
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $14k | 89k | 0.16 |